EMERADE 500 micrograms, solution for injection in a pre-filled pen 2 pens of 0.5 ml
Active ingredients: Epinephrine, Epinephrine bitartrate
Commercialized according to BDPMDispensing in France: Prescription only
Solution for injection2 pens of 0.5 mlintramusculaire
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- EMERADE 500 microgrammes, solution injectable en stylo prérempli
- Pharmaceutical form
- solution injectable
- Route of administration
- intramusculaire
- Presentation description
- 2 stylos préremplis en verre de 0,5 mL
- Marketing authorisation holder
- BAUSCH HEALTH IRELAND (IRLANDE)
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 28 Feb 2024
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
67644301CIP73003891CIP133400930038918Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| ADRÉNALINEsolution | 0,50 mg · 0,50 ml de solution | FT |
| TARTRATE D'ADRÉNALINEsolution | — | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.